Liquidia Corp (FRA:LT4) Stock Price, Trades & News

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Financial Strength

6/10

Name	Current	Vs Industry
Cash-To-Debt	1.21
Equity-to-Asset	0.27
Debt-to-Equity	1.7
Debt-to-EBITDA	3.44
Interest Coverage	1.75
Piotroski F-Score	7/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	14.07	Distress Grey Safe
Beneish M-Score	16.27	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

10/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	91.7
	3-Year EBITDA Growth Rate	4.4
	3-Year EPS without NRI Growth Rate	-6.9
	3-Year FCF Growth Rate	-0.6
	3-Year Book Growth Rate	-28.5
	Future 3-5Y Total Revenue Growth Rate Estimate	99.65

Momentum Rank

3/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	83.81
	9-Day RSI	79.28
	14-Day RSI	76.85
	3-1 Month Momentum %	55.53
	6-1 Month Momentum %	81.71
	12-1 Month Momentum %	396.83

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	2.22
	Quick Ratio	2.03
	Cash Ratio	1.49
	Days Inventory	262.05
	Days Sales Outstanding	44.46
	Days Payable	126.01

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-10.6
	Shareholder Yield %	-1.81

Profitability Rank

3/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	91.82
	Operating Margin %	15.81
	Net Margin %	7.74
	EBITDA Margin %	18.68
	FCF Margin %	13.53
	OCF Margin %	16.59
	ROE %	46.41
	ROA %	7.48
	ROIC %	33.38
	3-Year ROIIC %	-12.55
	ROC (Joel Greenblatt) %	213.84
	ROCE %	27.12
	Moat Score	5
	Tariff Resilience Score	6

GF Value Rank

2/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	563.86
	Forward PE Ratio	24.09
	PE Ratio without NRI	563.86
	PEG Ratio	79.42
	PS Ratio	25.45
	PB Ratio	64.18
	Price-to-Tangible-Book	68.37
	Price-to-Free-Cash-Flow	219.89
	Price-to-Operating-Cash-Flow	172.36
	EV-to-EBIT	133.7
	EV-to-EBITDA	129.79
	EV-to-Revenue	24.24
	EV-to-Forward-Revenue	12.12
	EV-to-FCF	178.35
	Price-to-GF-Value	0.35
	Price-to-Graham-Number	41.42
	Price-to-Net-Current-Asset-Value	176.05
	Earnings Yield (Greenblatt) %	0.75
	FCF Yield %	0.56

Financials (Next Earnings Date:2026-08-12 Est.)

Annual Quarterly TTM

FRA:LT4's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Liquidia Corp Executives

Details

GF Value™: €200.4

FRA:LT4

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 4 Severe warning signs with LT4. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	247.475
	EPS (TTM) (€)	0.119
	Beta	2.2181
	3-Year Sharpe Ratio	1.19
	3-Year Sortino Ratio	3
	Volatility %	93.34
	14-Day RSI	76.85
	14-Day ATR (€)	2.167356
	20-Day SMA (€)	62.048
	12-1 Month Momentum %	396.83
	52-Week Range (€)	10.21 - 73.48
	Shares Outstanding (Mil)	88.93

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	7
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Liquidia Corp Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Liquidia Corp Stock Events

Financials Calendars

Event	Date	Price (€)
Third quarter earnings conference call for 2026	2026-11-03 08:30	In 123 days
Third quarter earnings results for 2026	2026-11-03	In 122 days
Second quarter earnings conference call for 2026	2026-08-12 08:30	In 40 days
Second quarter earnings results for 2026	2026-08-12	In 39 days
General meeting for 2026	2026-06-16 16:30	59.90 (-2.06%)
Guidance call for 2026	2026-06-03 12:45	50.08 (+0.00%)
H.C. Wainwright 4(th) Annual Bioconnect Investor Conference at NASDAQ	2026-05-19 09:30	48.49 (+0.00%)
Guidance call for 2026	2026-05-13 08:40	44.56 (+0.00%)
First quarter earnings conference call for 2026	2026-05-11 08:30	36.27 (+1.68%)
First quarter earnings results for 2026	2026-05-11	36.27 (+1.68%)

Show

Entries

Liquidia Corp Frequently Asked Questions

What is Liquidia Corp(FRA:LT4)'s stock price today?

The current price of FRA:LT4 is €70.42. The 52 week high of FRA:LT4 is €73.48 and 52 week low is €10.21.

When is next earnings date of Liquidia Corp(FRA:LT4)?

The next earnings date of Liquidia Corp(FRA:LT4) is 2026-08-12 Est..

Does Liquidia Corp(FRA:LT4) pay dividends? If so, how much?

Liquidia Corp(FRA:LT4) does not pay dividend.

Press Release

	Subject	Date
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA	2024-11-02
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA	2024-10-25
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA	2024-10-17
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA	2024-10-09
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA	2024-10-03
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA	2024-09-25
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA	2024-09-17
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA	2024-09-09
	Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings	2024-09-06
	Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings	2024-09-05

10/Page

Articles on Liquidia Corp

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.